We're 10 days away from the AGM and the price seems to have formed a base at around 1.8c either waiting for further interest to climb further north or retrace back to lower levels.
I like to get some questions together for the CEO to have ready to respond to.
Feel free to post questions or email privately on [email protected] and I will compile a list and email to Ross M
The questions will be submitted without identification.
My questions are:
1. Is the company realistically still expecting Daptomycin TPM to be on the market by end 1Q 2017?
2. If yes, what regulatory and procedural steps still need to occur (separate from arbitration issues) for this to occur? If no, when is the revised date?
AGM questions
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.508M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $3.607K | 1.445M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 102396408 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 21041400 | 12 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVE (ASX) Chart |